Quality of Life Assessment: Key Issues in the 1990sS.R. Walker, Rachel M. Rosser Springer Science & Business Media, 2012 M12 6 - 487 pages It was over five years ago that the Centre for Medicines Research organized a workshop entitled "Quality of Life: Assessment and Application". This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life for well over a decade, whilst others were meeting the subject for the first time. This blend of experienced researchers and enthusiastic newcomers was a great stimulus to the discus sions which followed individual presentations as well as that resulting from the study groups. In the ensuing publication, a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the application of such assessments to specific clinical conditions which necessitated this approach. The organization in 1991 of a second workshop entitled "Quality of Life Assessment: Key Issues in the 1990s" resulted in a further consideration of the quality of life philosophy, concepts and key instruments together with an update on assessing quality of life in a number of major disease areas. Of particular importance was an examination of various viewpoints concerned with ethical questions and their implications, and quality oflife from industry, regulatory and health care purchasers' perspectives. As a result of this second workshop, the editors of the original book referred to above decided to produce a second edition with a number of updates and additional chapters. |
From inside the book
Page viii
... individual presentations as well as that resulting from the study groups . In the ensuing publication , a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the ...
... individual presentations as well as that resulting from the study groups . In the ensuing publication , a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the ...
Page 5
... individual practitioners , to a highly organized enterprise of large - scale proportions . The growing central- ization of decision - making has created roles for people ( who may or may not be physicians ) with a common responsibility ...
... individual practitioners , to a highly organized enterprise of large - scale proportions . The growing central- ization of decision - making has created roles for people ( who may or may not be physicians ) with a common responsibility ...
Page 7
... individual therapy , they are not readily communicated to others in a way that can be collected and analysed for ... individuals , but decisions which affect many individuals , for example , shall this drug be allowed for reimbursement ...
... individual therapy , they are not readily communicated to others in a way that can be collected and analysed for ... individuals , but decisions which affect many individuals , for example , shall this drug be allowed for reimbursement ...
Page 9
... individual preferences . There is also a large body of literature to support individual variation in the way various health states are rated . However , introspection and empirical data also support the argument that , despite the ...
... individual preferences . There is also a large body of literature to support individual variation in the way various health states are rated . However , introspection and empirical data also support the argument that , despite the ...
Page 11
... individual patients and to aggregates of patients . With individual patients , the health - care provider wishes to assess the lives of individual patients and to evaluate the potential and actual impact of treatments on them . Patients ...
... individual patients and to aggregates of patients . With individual patients , the health - care provider wishes to assess the lives of individual patients and to evaluate the potential and actual impact of treatments on them . Patients ...
Contents
11 | |
rationale for a single | 65 |
Development testing and use of the Sickness Impact | 95 |
The Nottingham Health Profile | 111 |
an update | 131 |
A health index and output measure | 151 |
A fifteendimensional measure of healthrelated quality | 185 |
The EuroQol quality of life project | 197 |
Measurement of healthrelated quality of life in asthma | 301 |
Measuring quality of life in hypertension | 321 |
Measuring the quality of life of patients with angina | 333 |
Measuring quality of life in psychiatry | 343 |
Measuring the quality of life of patients with skin disease | 355 |
Ethical questions and their implication for QOL studies | 373 |
Industry perspectives on quality of life | 383 |
A regulatory view | 393 |
Indices versus profiles advantages and disadvantages | 209 |
The OnLine Guide to QualityofLife Assessment | 221 |
Measuring the quality of life of patients with cancer | 235 |
Measuring the quality of life of patients with rheumatoid | 269 |
Measuring the quality of life of patients with Parkinsons | 289 |
The cost effectiveness of pharmaceuticals | 401 |
Requirements for health care purchasers | 413 |
The importance of quality of life in policy decisions | 427 |
Appendices | 441 |
Other editions - View all
Quality of Life Assessment: Key Issues in the 1990s S R Walker,Rachel M Rosser No preview available - 1992 |
Quality of Life Assessment: Key Issues in the 1990s S.R. Walker,Rachel M. Rosser No preview available - 2012 |
Common terms and phrases
ACE inhibitors activities airways disease analysis angina antihypertensive application areas aspects Assessment of Quality asthma atenolol auranofin behaviour benefits cancer patients captopril chronic cilazapril clinical trials clinician compared comparison components concepts coronary correlation cost depression dimensions disability distress domains drug dysfunction effects evaluation example factors function scores groups health services health status measures health-related quality hospital hypertension illness impairment important improvement indicators individual instrument interventions interview investigator Kaplan levodopa measure of health measurement of quality medicine methodological methods methyldopa mobility morbidity mortality nifedipine outcome overall pain Parkinson's disease performance physical function placebo population problems propranolol psychiatric psychological psychometric psychosocial QALY questionnaire questions reliability respiratory response rheumatoid arthritis Rosser scale self-administered sensitivity Sickness Impact Profile side-effects SIP score specific standard standard gamble statistical surgery symptoms Table testing therapy treatment validity valuation verapamil weights well-years